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Abstract
The occurrence of neurodegenerative diseases (NDs) increases with extended life expectancy.
The rise in elderly populations is resulting in an increased incidence of cognitive impairment,
and a high risk for developing dementia. Oxidative stress is implicated in the pathogenesis of a
number of neurovascular disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease
(PD). It has also been linked to disruption of blood brain barrier (BBB) in hypoxic-ischemic
injury. As part of the neurovascular unit, pericytes are inevitably subjected to insult from oxygen
and nitrogen radicals, generated in the central nervous system (CNS), leading to cell dysfunction
or damage.
In this research, we studied the effect of oxidative stress on cerebro-vascular pericytes cellular
function and determined how oxidative stress changes pericytes protein expression, including Factin, α-actin, platelet-derived growth factor receptor beta (PDGFR-β), tropomyosin and myosin.
In vitro, human brain vascular pericytes cell cultures were exposed to hydrogen peroxide (H2O2)
to mimic the cerebral ischemic condition then evaluate the cytotoxicity by MTT viability assay,
LDH assay and quantity of cellular morphology deterioration. Intracellular Proteins expression
level was examined by quantitative immunefluorescent microscopy. Proteins were labeled with
specific primary antibodies and corresponding secondary antibodies, conjugated with different
fluorescent probes. Results from cytotoxicity tests suggest that when we exposed the pericytes
cells to 100 and 200 µM for 1 hour, it showed the toxic effect of H2O2 on the pericytes cells
without killing the cells. Our data reveals that after mild oxidative stress, pericytes protein
expression intensity increased, changed position and moved toward the cell membrane while
sometimes forming cellular protrusion connecting cells together. These results indicate that
oxidative stress can affect pericytes cell contraction and cell movement.
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CHAPTER 1
Introduction
1.1 Oxidative Stress
Oxidative stress is a state where excess reactive oxygen species (ROS) overwhelm the
endogenous antioxidant system. Oxidative stress is involved in pathogenesis of many
neurovascular disorders such as Alzheimer’s disease (AD), Parkinson’s disease and multiple
sclerosis (Coyle & Puttfarcken, 1993). Oxidative stress also causes disruption of blood brain
barrier (BBB). Moreover, oxidative stress causes injury to neurons and alters astrocyte functions
(Robb & Connor, 1998). ROS induces pericytes contraction (Attwell et al., 2010).
1.2 Blood Brain Barrier (BBB)
Blood brain barrier is a complex structure that regulates the flow of the ions,
macromolecules and leukocytes into and out of the brain. BBB is formed by brain microvascular endothelial cells (BMVEC), pericytes and astrocytes. BBB disruption, induced by
infection, trauma or autoimmunity disease, initiates the parenchymal inflammation and facilitates
the leukocytes entry into the brain parenchyma via par-cellular route (Schenkel et al., 2004).
Immune cells cross BBB through the trans-cellular route (Doulet et al., 2006). Migration of
leukocytes is mediated by leukocytes –endothelial interaction and chemokine secretion by
BMVEC, astrosytes and microgalia (Cullere et al., 2005; Yang et al., 2005). Loss of BBB
integrity occurs in many neurological diseases, such as Alzheimer’s disease, Parkinsonism
disease, ischemia and multiple sclerosis.
1.3 Human Brain Microvascular Pericytes
In 1873, French scientist Charles- Mari Benjamin Rouget described pericytes cells and
named them Rouget cells (Rouget, 1873). Fifty years later, Zimmermann renamed these cells
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pericytes due to their anatomical location in the endothelium (Dalkara et al., 2011).
Cerebrovascular pericytes are small cells located in the outer layer of the brain capillary,
between the endothelial cell layer and the parenchyma. They are separated from the parenchyma
by the basal lamina (Franket al., 1987). Recruitment of pericytes to the vessel wall in the
embryonic brain regulates the development of the cerebral microcirculation and the blood brain
barrier (BBB). This is mediated by endothelial secreted platelet derived growth factor-B (PDGFB) and platelet derived growth factor receptor beta (PDGFR-β) interaction (Hellstorm et al.,
1999; Tallquistet al., 2003). Pericytes play an important function in angiogenesis, vessel
stabilization, endothelial cell regulation and maintenance of the blood-brain barrier (Bell et al.,
2010; Herman et al., 1985). Pericytes also show macrophage-like activity (Lai & Kuo, 2005).
They are also contractile cells, involved in regulation of capillary blood flow in response to
vasoactive agents and neural activity (Dore-Duffy et al., 2006; Hamilton et al., 2010).
1.4 Neurodegenerative Diseases and Oxidative Stress
Neurodegenerative diseases are diseases of the brain and spinal cord nerve cells. They
may be presented as function loss, which lead to ataxia or sensory dysfunction and dementia
(Mattson, 2004). Oxidative stress (OS) leading to free radicals attack on neural cells. This free
radicals play a significant role in neurodegenerative diseases such as Parkinson’s disease (PD),
Alzheimer’s disease (AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS)
(McCord, 2000). Toxicity of free radicals contributes to protein and DNA injury, inflammation,
tissue damage and subsequent cellular apoptosis (Fridovich, 1999). The incidence of
neurodegenerative diseases (NDs) increases with extended life expectancy. Alzheimer’s disease
(AD) is the most common neurodegenerative disease and it affects approximately 4.5 million
Americans and 16 million people worldwide (Gandhi et al., 2012).
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1.5 Thesis Outline
Chapter 2 was a literature review of oxidation stress and its role in neurodegenerative
diseases. The chapter also included a literature review of pericytes, anatomical and histological
structure and function, role in normal activity and role in disease states. Chapter 3 discused
methods and materials used to create and evaluate results obtained from this study. Chapter 4
displayed all results observed in the study regarding effect of oxidative stress in pericytes. Lastly,
chapter 5 presented a discussion of the results revealed and suggested future studies.
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CHAPTER 2
Literature Review
2.1 Oxidative Stress
Oxygen is essential for any cell life. However, the metabolism byproduct of oxygen
produces reactive oxygen species (ROS), which are toxic to cells. Oxidative stress is the state of
imbalance that results from a production of (ROS) that exceeds the ability of antioxidant defense
mechanisms (Poon et al., 2004). Early in life, 1-2% of O2 consumed is converted to ROS, but
this percentage increases in an aged brain due to the reduction of antioxidants and the low
regenerative capacity of an aged brain (Lepoivre et al., 1994).
2.1.1 Reactive oxygen species (ROS). ROS refers to the reactive molecules containing
oxygen. These include free radicals and are able to produce oxidative changes in the cells
(Migliore et al., 2009; Zhang et al., 2008). ROS sources include 1) mitochondrial electron
transport chain (Barja, 2004); 2) Proximal fatty acid metabolism; 3) Cytochrom P-450 reactions
(Beckman et al., 1998; Harman, 1992). ROS include superoxide (O2•−), hydrogen peroxide
(H2O2), and the hydroxyl radical (OH•). ROS lead to neurodegeneration by modulating the
function of biomolecules, which results in oxidative damage to macromolecules, as lipids,
proteins and nucleic acids (Poon et al., 2004; Stadtman, 2004). ROS attack glial cells and
neurons leading to neuronal damage (Gilgun-Sherki et al., 2001).
2.1.2 Oxidative stress and neurodegenerative disease. Oxidative stress plays an
important role in the etiology of many late onset degenerative diseases. Aging is the most
important risk factor for the common neurodegenerative diseases such as Alzheimer’s disease
and Parkinson’s disease. Lin et al.(2006) studied the relation between age and neurodegenerative
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diseases. They found that mitochondria are important regulators of cell death. Oxidative stress
leads to mitochondrial DNA mutation and dysfunction.
2.1.2.1 Alzheimer’s disease (AD). Alzheimer’s disease (AD) is the most common
neurodegenerative disease and it affects approximately 4.5 million Americans and 16 million
people worldwide. By 2050, it is projected that approximately 13 million people in the USA and
100 million people worldwide will be affected by this disease (Hebert et al., 2003).
Alzheimer’s disease is a progressive brain disease that slowly destroys memory and thinking
skills. AD patient may develop behavioral changes with time. Many studies show evidence of the
toxic effect of oxidative stress products on AD brain. Mecocci et al. (1994) reported that
oxidative stress affects DNA in the parietal cortex of the AD patient, mainly mitochondrial DNA
and, to a lesser extent, nuclear DNA. Hensley et al. (1995) observed that protein oxidation occurs
in elderly people with or without AD, but it is more severe in AD patients. Studies by Palmer et
al. (1994) and Marcus et al. (1998) show increased lipid peroxidation in the brains of AD
patients, mainly in the temporal lobe. Perry et al. (2003) and Nelson et al. (2009) found that,
approximately, 90% of AD patients have olfactory dysfunction. Evidence of oxidative stress has
been observed in the olfactory epithelium of AD patients. There is lipid peroxidation in the
nuclear and cell membrane of olfactory neurons and epithelial cells. Neurofibrillary tangles
formation and amyloid β peptide deposition lead to extensive cell loss and olfactory dysfunction.
There are many studies about Alzheimer’s disease pathogenesis and its relation to oxidative
stress. Lovell et al. (1995) reported that Alzheimer’s disease is characterized by progressive
neuronal loss and aggregation of protein extracellular and intracellular, forming extracellular
amyloid β (βA) plaques, and forming intracellular tau tangles. ROS lead to increased levels of
malondialdehyde and 4-hydroxynonenal in the brain and cerebrospinal fluid of AD patients.
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2.1.2.2 Parkinson's disease (PD). Parkinson's disease is a common adult-onset
neurodegenerative disorder. It is the second most common neurodegenerative disease,
characterized by a degeneration of the dopamine cell in the substantia nigra and aggregation of
the protein α-synuclein. Oxidative stress plays a major role in the initiation and progression of
PD. Many studies report that oxidative stress leads to lipid, protein, and DNA damage. A study
by Dalfó et al. (2005) showed that polyunsaturated free fatty acids concentration in the substantia
nigra is decreased but levels of lipid peroxidation markers, such as malondialdehyde and 4hydroxynonenal, are increased. These can react with proteins to impair cell viability. Brown et
al. (2004) reported that reactive nitrogen species lead to nitration and nitrosylation of certain
proteins. Moreover, research by Bender et al. (2006) showed that oxidative stress leads to
increased deletions in mitochondrial DNA in the dopaminergic neurons in PD substantia nigra.
Many studies have focused on the relation between PD-related genes (PINK1, DJ-1, Parkin) and
mitochondrial function. Lev et al. (2008), for example, reported that DJ-1 in mitochondria has an
antioxidant effect and loss of its function leads to oxidative stress. Researchers (Crompton et al.,
2002; Giorgio et al., 2010) have also studied the PINK1gene, which is a mitochondrial kinase.
Studies reported that PINK1 deficiency leads to impairment of mitochondrial calcium efflux and
mitochondrial calcium overload. Reaction between calcium and ROS leads to an opening of the
mitochondrial permeability transition pore (PTP). When opened, PTP allows molecules to escape
to cytosol, causing cell death. The reaction between PINK1act and Parkin was investigated in
several studies (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010). Such
studies reported that PINK1act with Parkin to regulate the clearance of damaged mitochondria
via autophagy. Mutations in either Parkin or PINK1 lead to a failure of mitophagy and an

9
accumulation of dysfunctional mitochondria, which causes more production of ROS and more
oxidative stress to the neuron.
2.1.3 Mechanisms of oxidation stress. Oxidation stress occurs when ROS exceeds the
ability of antioxidant defense mechanisms. ROS can be increased due to mitochondrial
dysfunction. Direct activation of NADPH oxidase can also cause oxidation stress.
2.1.3.1 ROS production by mitochondrial dysfunction. The mitochondria have been
identified as a major source of ROS. It produces free radicals due to a defect in the electron
transport chain. This electron transport chain is a complex enzymatic system consisting of 5
distinct phases: complex 1 (NADH dehydrogenase), complex 2 (succinate dehydrogenase),
complex 3 (ubiquinol–cytochrome-c reductase), complex 4 (cytochrome-coxidase), and complex
5 (ATP synthase). Rodrigo, Miranda, and Vergara (2011) reported that mitochondria is a major
source of cellular (O2•−) production from Complex I and from Complex III by the transfer of one
electron to O2. According to this theory, inhibition of mitochondrial complex will induce
oxidative stress. Also, mitochondria produce ROS via the enzyme family of monoamine oxidase
(MAO), which bind to the outer mitochondrial membrane and catalyze the oxidation of biogenic
amine neurotransmitters, such as, nor epinephrine, dopamine, and serotonin. MAO-B catalyzes
the oxidation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) to (MPP⁺), which
inhibits mitochondrial complex I (Lotharius et al., 2000; Smith et al., 1997).
2.1.3.2 ROS production via NADPH oxidase. A lot of researchers studied the NADPH
oxidase and its role on oxidative stress in Alzheimer’s disease. Bianca et al. (1999) reported that
Amyloid β leads to the direct activation of NADPH oxidase in rat microglial cells
and human phagocytes. Furthermore, Abramovet al. (2003) reported that Amyloid β activate
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NADPH oxidase through increased calcium influx into astrocytes. The activation of NADPH
oxidase leads to the generation of oxidative stress.
2.2 Brain Microvascular Pericytes
2.2.1 What are pericytes? They are contractile cells found on almost all capillaries,
small arterioles and venules walls. Rouget C (1873) was the first scientist to describe pericytes
and termed them Rouget cells. Zimmermann K (1923) coined the term Pericytes because of their
location around microvessels. Frank et al. (1987) described the pericytes and their location,
clarifying that pericytes are tiny cells situated on the outer layer of the vessel, between the
endothelial cell layer and the parenchyma. They are surrounded by basal lamina, which separates
them from endothelial cells and parenchyma. Shepro et al. (1993) reported that pericytes send
out primary projections along the vessel in each direction, then from this projection, they send
secondary and, maybe, tertiary processes projections around the vessel. Additionally,
Morphological studies of pericytes showed that pericytes have a heterochromatic nucleus (D. E.
Sims, 1986). The cytoplasm of pericytes contains mitochondria, ribosomes, Golgi apparatus,
lysosome, rough and smooth endoplasmic reticulum (David E. Sims, 2000). Pericytes have
primary processes along the vessel wall and secondary processes, which go around the vessel
wall (Krueger et al., 2010).

Figure 1. Capillary neurovascular unit (Hamilton et al., 2010).
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2.2.2 Pericytes functions. Many studies have investigated the function of pericytes and
their role in normal physiology. Pericytes play an important role in the maintenance of the bloodbrain barrier, vessel stabilization, endothelial cell regulation and angiogenesis (Hirschi et al.,
1996; Krueger et al., 2010; C. H. Lai et al., 2005). Pericytes show macrophage-like activity (W.
E. Thomas, 1999). They also act as precursors for several different cell types, forming neurons
and glia in the CNS (Bonkowski et al., 2011; Dore-Duffy et al., 2006). Early researchers thought
that pericytes are contractile cells because of their prevascular location and that they may play a
role in the regulation of microcirculation blood flow (Dore, 1923). Researchers such as Frank et
al. (1987) and Shepro et al.(1993) studied pericytes in the central nervous system and they found
that there are more pericytes per endothelial cell in CNS more than anywhere else. This indicates
that pericytes might play a particularly specific role in the nervous system.
2.2.2.1 Regulation of capillary blood flow. Capillary pericytes are contractile cells,
which can respond to many vasoactive stimuli. Electron microscopic studies reported that
pericytes have microfilament around the nucleus and within the primary and secondary
processes. These microfilaments contain actin, myosin, or tropomyosin (Hamilton et al., 2010;
David E. Sims, 2000). Such results correspond with immunoelecton microscopy and
immunohistochemical studies of retinal and brain pericytes (Bandopadhyay et al., 2001).
Dehouck et al. (1997) found that activation of endothelin- 1 receptors lead to an elevation of the
intracellular calcium concentration. This in turn, leads to vasoconstriction of cultured capillary
pericytes. Recently, more studies on rat and mouse were performed to confirm that pericytes are
contractile cells that can regulate blood flow. Peppiatt et al. (2006) stimulated retinal and
cerebellar rat pericytes with ATP and noradrenalin and detected the contraction of capillary

12
pericytes with differential interference contrast microscopy. In a study by Fernández-Klett et al.
(2010), the authors reported that vasoactive stimuli in an intact adult mouse brain lead to the
contraction of cortical capillary pericytes. Constrictions were more prominent at pericytes
bodies, which reflected changes in pericytes contractile tone. This lead to changes in the
capillary diameter associated with significant changes in blood flow. Furthermore, Webb (2003)
reported that smooth muscle contraction or relaxation depended on intracellular calcium
concentration. Elevation of intracellular calcium concentration leads to activation of myosin light
chain kinase. This generates contraction by phosphorylating the myosin light chain (MLC) and
prompting its interaction with α-SMA. Low calcium levels leads to the relaxation of the smooth
muscle.
2.2.2.2 Pericytes and regulation of BBB. The blood-brain barrier (BBB) is considered a
physical barrier. BBB is formed by the endothelial cell, extracellular matrix, astrocytes and
pericytes. The role of pericytes in the regulation of BBB is emphasized in the study byArmulik et
al. (2010). An in vivo study of adult mouse pericytes reported that the close interaction between
the endothelial cells and pericytes are important for BBB development. The study also reported
that the capillaries permeability depends on pericytes number. Pericytes deficiency increases the
permeability of the BBB to water and molecules. Daneman et al. (2010) reported that pericytes
induce the formation of tight junctions and inhibit the expression of molecules that increase
vascular permeability. Al Ahmad et al. (2009) reported that in many cerebrovascular diseases,
pericytes can be detached from the vessel wall, leading to impairment in BBB and resulting in
decreased tight junction expression and increased pinocytic activity. Quaegebeur et at. (2010)
reported that pericytes in healthy conditions release molecules to brain endothelial cells in order
to maintain the BBB integrity. Pericytes also secure normal perfusion and vasoregulation. BBB
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lose integrity when pericytes lost under pathological condition lead to decreased vessel
vasoreactivity, hypoperfusion and hypoxia. Leakage of neurotoxic substances leads to abnormal
endothelial junctions, transcytosis, and astrocyte polarization.

Figure 2. Roles of pericytes in BBB integrity and brain perfusion (Quaegebeur et al., 2010).
2.2.2.3 Pericytes and angiogenesis. Angiogenesis is the process of new blood vessels
formation. This process requires two types of cells, endothelial cell and pericytes (Gerhardt &
Betsholtz, 2003). A study by Lindahl et al. (1997) investigated the reaction between the
endothelial cells and pericytes cells. He reported that endothelial cells secrete PDGF-B, which
binds to PDGFR-β receptor in pericytes. This interaction is essential for the presence of pericytes
in the vessels wall. Abramsson et al. (2007) studied the role of Heparin sulfate (HS) in pericytes
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recruitment, using two mouse models with altered HS biosynthesis. The authors concluded that
pericytes recruitment requires sufficient amounts of HS to maintain PDGF-B and activate PDGF
receptor β (PDGFR-β) signaling.
2.2.3 Role of pericytes in pathological conditions. Pericytes damage has been linked to
several pathological conditions. Various researchers (M. Hellstrom et al., 2001; Kamouchi et al.,
2004; Puro, 2007) found that the contractile activity of pericytes is regulated by intracellular Ca2⁺
concentration. Many factors may cause an uncontrolled rise in intracellular Ca2⁺. ROS may be
one of these factors. A study by Yemisci et al. (2009) states that ROS produced by endothelium
and astrocyts on the microvessel wall cause pericyte contraction. Mathiisen et al. (2010)
reported that mitochondrial pericytes may be a good source for ROS under pathological
conditions. An in vitro study by Kamouchi et al. (2007) showed that ROS causes sustained
increase in Ca2⁺ in cultured human brain pericytes. Moreover, a study by Yemisci et al. (2009)
performed in an intact mouse brain showed that ROS causes pericyets contraction. So, excessive
ROS and Ca2⁺ dysregulation lead to the dysfunction of pericytes and the loss of signaling
between pericytes and surronding cells.
2.2.3.1 Alzheimer’s disease. Pericytes play an important role in pathogenesis of
Alzheimer's disease. Wilhelmus et al. (2007) reported that β-amyloid deposition around
capillaries in Alzheimer's patient brain is toxic to pericytes. He reported also that pericytes may
be directly involved in β-amyloid clearance across the blood-brain barrier. Many researchers
investigated the causes of β-amyloid clearance insufficiency. Weller et al. (2008) reported that
this may be due to overproduction of β-amyloid or due to decreased functioning of the clearance
pathways. (Niwa et al., 2001; T. Thomas et al., 1996) reported that the β-amyloid react with the
endothelial cells and release a superoxide radicals, which lead to vasoconstriction, endothelial
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cell damage and a decrease in cerebral blood flow in larger blood vessels. This also causes a
decrease in the response of cerebral blood vessels to neuronal activity or to endotheliumdependent vasodilators.
2.2.3.2 Diabetic retinopathy. Visual loss due to retinopathy is one of the most common
complications of diabetes mellitus. Retinopathy is characterized by acellular capillaries,
microaneurysms, hemorrhages, macular edema and angiogenesis (Cogan et al., 1961). Retinal
capillaries have a higher number of pericytes more than in any other vascular bed in the body
(Frank et al., 1987; Shepro et al., 1993). Loss of pericytes in the retinal microvessels is the most
important feature of diabetic retinopathy. Interaction between pericytes and endothelial cells is
important to keep pericytes on retinal capillaries. Platelet-derived growth factor-B (PDGF-B) is
produced by endothelial cells, while its receptor, PDGFR-β is expressed on pericytes. Lindhal et
al. (1997) reported that PDGFR-β knockout mice showed microvascular pericytes loss and
developed numerous capillary microaneurysms that ruptured later. Pericytes are important to
maintain retinal capillary stability and prevent microaneurysm formation. Geraldes et al. (2009)
addressed that there is a possible link between Diabetes and PDGFR- β deficiency. He reported
that the high glucose levels lead to activation of protein kinase C-δ and decrease signaling
pathway in pericytes, which leads to PDGFR-β phosphorelation, causing pericytes apoptosis and
loss. He also reported that activation of protein kinase (p38αK) leads to generation of ROS that
cause activation of nuclear factor κB (NF-κB) and activation of SHP-1(Src homology-2 domaincontaining phosphatase-1). This inhibits PDGFR-β and stops the reaction between the
endothelial cell and pericytes. Ejaz et al. (2008) spotted that protein kinase C-δ lead to activation
of NF-kB and pericytes apoptosis.
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2.2.3.3 Cerebral ischaemia. Cerebral ischaemia refers to the interruption of cerebral
blood flow at the capillary level. Peppiatt et al. (2006) studied the role of pericytes in retinal and
cerebral ischaemia. The authors reported that capillary pericytes contracted during retinal
ischaemia and transient cerebral ischaemia. They found that pericytes can control capillary
diameter in the whole retina and cerebellar slices. Electrical stimulation of retinal pericytes
started a capillary constriction. Superfused ATP in retina or nor adrenaline in cerebellum resulted
in constriction of capillaries by pericytes. This suggests that pericytes are probably modulators
of blood flow in response to changes in neural activity. Yemisci et al. (2009) reported that
contracted pericytes induced segmental narrowing of the capillary lumen, leading to clogged
circulation. Further, del Zoppo et al. (2003) reported that capillary contraction induced by
pericytes contraction may delay the passage of blood cells and promote their aggregation with
fibrin.
Several electron microscopic studies reported that after ischaemia, pericytes migrate away
from the vessel wall (Gonul et al., 2002; Melgar et al., 2005; Takahashi et al., 1997). This
migration started at the time of hypoperfusion and continued for at least 12–24 hours. Pericytes
that did not migrate showed cytoplasmic changes and degeneration. This suggests that migration
may protect the pericytes from death or cell death prevent cell from migration.
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Figure 3. Pericytes in disease states (Hamilton el al., 2010).
A) In Alzheimer's disease: β-amyloid, which aggregates around blood vessels, is toxic to
pericytes and produces superoxide (O2•−) leading to vessel contraction.
B) In cerebral ischaemia: capillary blockade by polymorphonuclear leukocytes, generation of
reactive oxygen species and capillary constriction lead to failure of capillaries reperfusion.
C) In diabetic retinopathy: high glucose levels prompt pericytes apoptosis via activation of
protein kinase C δ (PKCδ) and activation of protein kinase (p38αK). This generates ROS that
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cause activation of nuclear factor κB (NF-κB) & activation of SHP-1(Src homology-2 domaincontaining phosphatase-1), which inhibits PDGFR-β and stops the reaction between the
endothelial cell and pericytes.
2.3 Purpose
The purpose of this thesis is to study the effects of oxidative stress on human brain
vascular pericytes cellular function and determine how oxidative stress changes the pericytes
protein expression. The literature review has identified that ROS are able to produce oxidative
changes in the cells (Migliore et al., 2009; Zhang et al., 2008). Oxidative stress may alter
intracellular calcium load in pericytes by interfering with mitochondria and calcium pump,
which may account for the sustained calcium rise and pericytes contraction ( Kamouchi et al.,
2007; Yemisci et al., 2009). Pericytes contraction cause capillary contraction and may delay the
passage of blood cells and promote their aggregation with fibrin (del Zoppo et al., 2003).
Therefore, there is an urgent need to illustrate what and how oxidative stress may alter pericytes
cellular function in details. The hypothesis of this study is that oxidative stress affects cerebrovascular pericytes cellular function and leads to increased pericytes protein expression level,
which promotes pericytes contractility causing capillary contraction. The objectives are to: 1)
Evaluate the effect of oxidative stress on cerebro-vascular pericytes cellular function; recognize
the toxic concentration, and determine how long it took to show the toxic effect of H2O2 on the
human brain vascular pericytes cells without killing these cells through in vitro tests, including
MTT viability assay, LDH assay and Cell Morphology. 2) Determine how oxidative stress
changes pericytes protein expression, including F-actin, α-actin, PDGFR-β, tropomyosin and
myosin.
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CHAPTER 3
Methodology
Human brain vascular pericytes (HBVP) cells were tested in this study by exposing them
to H2O2 to investigate the toxic effect of H2O2 on the cell. Cultured cells are often exposed to
H2O2 concentration ranging from 100 µM to 1000 µM. Tests included cytotoxicity and
intracellular proteins expression level. The cytotoxicity assay measured the toxic effect of H2O2
on human brain vascular pericytes cells (HBVP) with an MTT viability assay, LDH assay and
quantity of cellular morphology deterioration. The intracellular proteins expression level is
examined by quantitative immunofluorescent microscopy.
3.1 Measuring H2O2 Concentration
To prepare fresh 225 mM stock H2O2, first dissolve 230 µl of 30% H2O2 in 9.77 ml of
sterile water then prepare 1:30 dilution and read the absorbance at 215 nm three times and
average them. To calculate H2O2 concentration, use the average absorbance and Beer –Lambert
Law (A=ɛbc), c = (A/ɛb)*dilution factor & C1V1= C2V2 and prepare different concentrations to
determine which concentration is toxic to the cells without killing them (Dr. Jenora Waterman,
personal communication).
3.2 Cytotoxicity Assay
Cytotoxicity tests are one method used to assess the toxic effect of H2O2 on cellular
function. Cell membrane integrity is the most common way to measure cytotoxic effects on cells.
There are many different ways to measure cytotoxicity, including 3-(4, 5-Dimethyl-2-thiazolyl)2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay (Promega, Madison, WI) and Lactate
Dehydrogenase (LDH) assay (Roche, Indianapolis, IN).
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3.2.1 Media preparation. Pericytes Medium (PM) is a medium created for optimal
growth of normal human vascular pericytes in vitro. It is a sterile, liquid medium, containing
essential and non-essential amino acids, vitamins, organic and inorganic compounds, hormones,
growth factors, trace minerals and a low concentration of fetal bovine serum (2%). This medium
is bicarbonate-buffered and has a pH of 7.4 when incubated with an atmosphere of 5% CO2 /95%
air. The medium is prepared to provide a balanced nutritional environment that selectively
promotes proliferation and growth of normal human vascular pericytes in vitro (ScienCell
Research Laboratories). PM consists of 500 ml of basal medium, 10 ml of fetal bovine serum
(FBS), 5 ml of pericytes growth supplement (PGS), and 5 ml of penicillin/streptomycin solution
(P/S). Thaw PGS, FBS and P/S solution at 37ºC then add PGS, FBS and P/S solution into a basal
medium in a sterile field stored at 4ºC.
3.2.2 Cell culture. HBVP cells purchased from ScienCell Research Laboratories
(Carlsbad, CA) were cultured in a T-75 poly-L-lysine coated flask (overnight coating) with
Pericytes Medium (PM), 2% of fetal bovine serum (FBS), 1% penicillin / streptomycin solution
(P/S) and 1% of pericytes growth supplement (PGS) at 37°C in a humidified atmosphere of 5%
CO2. Cells were first seeded from liquid nitrogen into poly-L-lysine coated T-75 flasks. Fresh
(PM) media was added after 24 hours to the flasks then cells were cultured for a minimum of 72
hours before a media change or subculture. Once the monolayer reached subconfluence (80%),
cells were subcultured by trypsinization. Cells were used for experiments at passage 3 or 4. To
prepare the cells for cytotoxicity tests, cells were seeded in poly-L-lysine coated 96-well plates at
2 x 104 cells/200 μl per well and incubated in a humidified atmosphere with 5% CO2 at 37°C for
72 hours to allow attachment and reach a high confluence (70%). The medium was then replaced
with a different concentration of H2O2 at different periods of exposure to determine the
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concentration and how long it takes to show the toxic effect on cells without killing the cell. Cell
culture plates were observed under an optical microscope. Experiments were run in triplicate to
ensure repeatability and decrease variation. The optical microscope was used to capture images
at different magnifications, including 10X, 20X and 40X to observe and compare cell
morphologies. Images were captured from each well and compared to the control well.
3.2.3 Optical microscope images of cell morphologies. In order to inspect the
morphologies of human brain vascular pericytes cells after exposure to different concentrations
of H2O2 at different period of time, an EVOS optical microscope (AMG, Grand Island, NY) was
used. The EVOS microscope, which is a transmitted light, digital-inverted microscope, was
applied with phase contrast settings to conduct a comparison of the morphologies of treated and
normal untreated pericytes cells.
3.2.4 Cell viability assay (MTT). Cell viability testing is a type of cytotoxicity testing
used to measure the toxic effect of substance or material on cells via viability. Viability is the
relative growth rate of treated cells compared to control cells, which are not treated. Viability is
significant, because it quantitatively measures the effect of substance exposure on cell growth.
There are various tests to quantitatively measure cytotoxicity. These tests include MTT (3-[4, 5dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromid), LDH (lactate dehydrogenase) and BrdU
(5-bromo-2'-deoxyuridine). Each test uses different biomarkers to determine the mechanism of
cell death. Those biomarkers are ATP, LDH and proteases.
In this study, MTT colorimetric assay was completed to calculate the number of viable
cells in proliferation or cytotoxicity assays using The CellTiter 96 AQueous One Solution.
The MTT assay reagent contains a novel tetrazolium compound [3-(4, 5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron-
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coupling reagent (phenazine ethosulfate; PES). The MTT assay is dependent on the reduction of
yellow tetrazolium salt MTT to purple formazan crystals in the mitochondria of living cells. This
cellular reduction is most likely achieved by NADH and NADPH (Promega, 2012).The test
should include a blank containing complete culture medium without cells to account for any
background noise from the solution when running the assay. The formazan crystals formed are
solubilized in tissue culture media and the resulting purple solution is quantified using a scanning
multiwall spectrophotometer. All through the MTT test, the 96-well plates were kept away from
direct light until crystals were completely solubilized. After 4 hours, a Spectra-Max M5 multiplate reader was used to read the resulting purple solution at 560 nm for absorbance
measurement. The amount of purple formazan product measured by the absorbance at 560 nm is
directly proportional to the number of living cells in culture.
In this study, we ran the MTT assay multiple times until we recognized the toxic
concentration and determined how long it took to show the toxic effect of H2O2 on the human
brain vascular pericytes cells without killing these cells. First, we subcultured the cell in 96- well
plate at 2 x 10⁴ cell/200 μl media and incubated them for 48 hours to allow attachment and
achieve a high confluence (70%). We tested the cytotoxicity in respect to concentration gradient
and time course. We prepare stock H2O2 by dissolving 230 μl of 30% H2O2 in 10 ml of sterile
water then prepare 1:30 dilution and read the absorbance at 215 nm three times and average
them. We used the average absorbance and Beer –Lambert Law (A=ɛbc), c = (A/ɛb)*dilution
factor & C1V1= C2V2 to calculate H2O2 concentration and prepare different concentration. In
concentration gradient, the time of exposure was 1 hour. The medium was replaced with a 100 μl
H2O2 concentration of: 0.1, 0.5, 1.0, 10 and 100 mM. At the same time, we had a control group
containing cells without treatment. Additionally, we had a row with only MTT and media to
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serve as background. Experiments were run three times each to ensure repeatability and decrease
variation. We captured some images with the EVOS optical microscope to investigate cell
morphologies then the plate was incubated in a humidified atmosphere with 5% CO2 at 37°C for
one hour. We added 10 μl of MTT kit to each well with a repeating pipette. We then incubated
the plate at 37°C for 4 hours in a humidified, 5% CO2 atmosphere. Then, we read the plate at
560 nm using Spectra-Max M5 multi-plate reader (Molecular Devices, Sunnyvale, CA) and
recorded the absorbance. We repeated the test using H2O2 concentration of: 0.1, 0.2, 0.5 and 1.0
mM and control. To calculate the result, we subtracted the average of absorbance values of the
culture medium background from all absorbance values of experimental values viability

Viability % =

X 100

(1)

In the time course we treated the cell with 200 µM H2O2 for different time periods: 4
hours, 3 hours, 2 hours, 1hour, 30 minutes and 0 minutes.
3.2.5 Lactate Dehydrogenase assay (LDH). It is colorimetric non radioactive assay,
which quantitatively measures lactate dehydrogenase (LDH). LDH is a stable cytosolic enzyme
that is released after cell lysis. LDH is present in all cells and it is rapidly released into the cell
culture supernatant when the plasma membrane is damaged. The assay was performed in a 96well plate. We used Roche cytotoxicity detection kit (LDH), which contains catalyst
(Diaphorase/NAD⁺ mixture) and Dye solution (INT and sodium lactate). The assay is dependent
on the cleavage of a tetrazolium salt when LDH is present in the culture supernatant. We
prepared a cell-free supernatant then incubated with INT to form colored formazan. The amount
of color formed is proportional to the number of lysed cells. There are two enzymatic reactions
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occurring here: first, LDH reduces NAD⁺ to NAD + H⁺ by oxidation of lactate to pyruvate.
Second, enzymatic reaction diaphorase (the catalyst) transfers H/H⁺ from NADH + H⁺ to the
tetrazolum salt INT. Visible wavelength absorbance data was collected using a Spectra-Max M5
multi-plate reader at 490 nm. As we did in the MTT assay, we also ran the LDH assay to
recognized the most toxic concentration and how long it took to show the toxic effect of H2O2 on
the human brain vascular pericytes cells. First, we subcultured the cell in a 96- well plate at
2x104 cell/200 μl media and incubated for 48 hours to allow attachment and achieve a high
confluence (70%). The medium was then replaced with the H2O2 to the desired test exposure
period. Following this, we collected the cell-free culture supernatant and centrifuged them (spin
at 1200 rpm for 5 min at 4º). We removed 100 µl supernatant and transferred it to another
microplate and added100 µl/well reaction mixtures to each supernatant and incubated for 30 min.
Experiments were run three times each to ensure repeatability and decrease variation. The
sample in the plate contained culture media background, which is required to correct for
contributions caused by phenol red and LDH activity that may be present in culture medium. The
sample in the plate also contained positive control (cell with maximum LDH release) by adding
lysis solution to the cell; negative control (cell with no LDH release), which is the cell without
exposure to the toxic substance, and the experimental sample (treated cell with different H2O2
concentration).
In this study, we performed the test with concentration gradient and time course. We used
H2O2 concentration of: 1, 0.5, 0.2, and 0 mM. To calculate the result, we subtracted the average
of absorbance values of the Culture Medium background from all absorbance values of
experimental, positive control and negative control, and then calculated the cytotoxicity with this
equation.
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% cytotoxicity =

X 100

(2)

In the time course we treated the cell with 200 µM H2O2 for different time periods: 4 hours, 3
hours, 2 hours, 1 hour, 30 minutes and 0 minutes.
3.2.6 Cellular morphology characterization. Cell morphology is an important sign of
toxicity in cells. To find out the morphological changes on cell after performing cytotoxicity
tasting, cell structure of treated cells is analyzed and compared to healthy untreated cells under
an optical microscope. We measured the morphological changes after 1 hour of treatment the
cells with 100 and 200 µM H2O2. Also we measured the morphological changes after treated the
cells with 200 µM H2O2 at different time period(0 h,0.5 h, 1h, 2h,3h and 4h). Morphology is
important, because cells will begin to deteriorate when the cellular structure is distorted or
impaired. Signs of deterioration of cells include granular nucleus, formation of cytoplasmic
vacuoles and cell detachment from surface. Measuring cell morphology deterioration is one way
of measuring cell toxicity on cells.
3.3 Intracellular Proteins Expression Level
We tried to check the protein expression level, including F-actin, α-actin, PDGFR-β,
tropomyosin and myosin. Intracellular Proteins expression level was examined by quantitative
immunofluorescent microscopy. Proteins were labeled with specific primary antibodies and
secondary antibodies, conjugated with different fluorescent probes.
3.3.1 Immunofluorescent staining of intracellular protein. The purpose of
immunofluorescence staining is to detect the location and amount of specific proteins in cells. In
this study, we detected F-actin using Actins green stain. We also detected α – Actin, PDGF-β,
myosin and tropomyosin, using primary and secondary antibodies to label these proteins. Using
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immunofluorescence, we can see when, where and how much protein is expressed in the
cell after exposure to H2O2. Cell staining can be divided into four steps: cell preparation,
fixation, application of antibody and evaluation. In cell preparation, the cell was attached to a
coverslip to allow solid support and easy handling in subsequent procedures. Fixing and
permeabilizing the cells ensures free access of the antibody to its antigen. Fixation immobilizes
the antigens. Permeabilization permits access of antibodies to all cells and subcellular
compartments. We fixed the cells with formaldehyde, which is a cross-linking reagent. Then, we
incubated cells with the primary and secondary antibodies. Finally, the staining was evaluated
using EVOS FL fluorescence microscopy.
First we autoclaved coverslips for 25 minutes and placed them in a 12-well plate coated
with poly L-lysine. We then subcultured 3x104 cells/well in1 ml of media and allowed them to
adhere on coverslips and reach 50-60% confluent for 2 days to be able to get good images under
the microscope. We then replaced the culture media with H2O2 (0, 100, 200 µM concentration)
and left them for one hour. We used triplicate coverslips for each concentration. Next, we
washed the coverslips twice with Phosphate Buffered Saline (PBS). We fixed the cells with 4%
formaldehyde for 15 minutes in room temperature. Fixation is important to retain the shape and
location of cellular protein. We washed three times with (PBS) for 5 minutes with shaking. Next,
we added 1% Triton X-100 in PBS for 5 minutes. Triton X-100 is a permeabilization reagent that
dissolves small holes in the cell membrane, giving antibodies access to cytoplasm and bind
proteins. Next, we washed twice in PBS (5 minutes/ wash). We covered the cells with blocking
solution. We used 5% goat normal serum in PBS. We incubated the samples for 1 hour in room
temperature with gentle shaking. Next, we diluted the primary antibody in 1% blocking solution
(1µl primary antibody for each 500 µl blocking solution). We incubated with sample overnight at
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4ºc with gentle shaking. We washed three times in PBS (5 minutes/wash) with gentle shaking.
We diluted the secondary antibody in 1% blocking solution (1µl primary antibody for each 1000
µl blocking solution). We incubated with sample for 1 hour with gentle shaking. We washed
three times in PBS (5 minutes/ wash) with gentle shaking. We diluted Actins green solution 2
drops in 1 ml PBS. We incubated the Actins green with cells for 1 hour, and then washed three
times in PBS (5 minutes/ wash) with gentle shaking. Next, we added one drop of anti-fade
reagent on the slide then flipped the coverslip on top of it. We then put the coverslip in 4˚
overnight. We took pictures with an immunofluorescence microscope.
3.3.2 Primary antibodies. Antibodies are an important material used to detect the
presence and the subcellular localization of an antigen in the cells. In our research, we used four
different antibodies to detect the proteins inside the cells.
3.3.2.1 α–Actin (1A4). Is a mouse monclonal antibody used to detect smooth muscle α–
actin of mouse, rat and human origin. Actin forms about 50% of total cellular protein. It detects
the protein by western blotting, immunofluorescence and solid phase ELISA. The dilution used
is different from test to test. Molecular weight of α-Actin: 43KDa.
3.3.2.2 PDGFR-β (958). Is a rabbit polyclonal antibody used to detect PDGF receptor
type β in a mouse, rat and human origin. PDGF consists of 2 chains, A and B, which form three
isoforms. These three isoforms bind with different affinities to two receptor types, PGDF-α and
β. Platelet-derived growth factor receptor-β is a rabbit antibody raised against amino acid of
PDGFR-β of human origin. PDGFR-β can bind to the B subunit of platelet-derived growth
factor. It detects the protein by western blotting, immunofluorescence and solid phase ELISA.
The dilution used is different from test to test. Molecular weight of PDGFR –β: 180-190KDa.
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3.3.2.3 Tropomyosin (FL-2840). Is a rabbit polyclonal antibody used to detect
Tropomyosin in the cell, which is a group of structural proteins binding actin filaments and
functioning to modulate actin-myosin interaction and stabilize actin filament structure. It is used
to detect 4 types of tropomyosin (α, β, γ,and 4) of mouse, rat and human origin by western
blotting, immunofluorescence and solid phase ELISA. The dilution used is different from test to
test. Molecular weight of tropomyosin: 31-47 KDa.
3.3.2.4 Myosin (FL-172). Is a rabbit polyclonal antibody raised against amino acids 1172 used to detect myosin. Myosin is a protein that interacts with actin to generate the force of
cellular movements. There are three classes of myosin: smooth muscle myosins, striated muscle
myosins and non-muscle myosins. They regulate contraction in smooth muscle and non-muscle
cells via phosphorylation by myosin light chain kinase (MLCK). The myosin antibody is used
for detection of myosin regulatory light chains (Santa Cruz biotechnology, INC).
3.3.3 Secondary antibodies. They are fluorochrome-labeled secondary antibodies used
to detect protein indirectly. In this experiment, we used rabbit anti mouse IGg and goat anti
rabbit IGg.
3.3.4 Immunefluorescent microscopy. The EVOS Fl digital inverted microscope
uses fluorescence to generate images. Antibodies are labeled with fluorochromes to allow
visualizing the protein inside the cells. These labeled antibodies bind indirectly or directly to the
antigen of interest. In the direct method, the antibody against the molecule of interest is
chemically conjugated to a fluorescent dye. But in the indirect method the antibody against the
molecule of interest is unlabeled. It is called primary antibody and should be used with labeled
secondary antibody.
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3.4 Statistical Analysis
Statistical analysis was performed using Graphpad prism software. One-way ANOVA
test (analysis of variance) was followed by Tukey test (all pairwise comparisons). Values are
presented as means ± S.D. from three replicates for cytotoxicity testes and from 8 pictures to
calculate the protein expreation intensity. Levels of significance and respective symbols are as
follows: significance, p ≤ 0.05, and no significance, ns.
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CHAPTER 4
Results
4.1 Cytotoxicity Tests
We used hydrogen peroxide (H2O2) to mimic the ischemic condition. The idea is to
introduce enough oxidative stress, which leads to pericytes activation but without killing the
cells. To determine the optimal concentration of hydrogen peroxide for this study, pericytes were
treated with different concentrations of hydrogen peroxide for different times. Cytotoxicity tests
(including MTT and LDH) and cell morphology measurements were implemented. Tests were
run in triplicate to ensure repeatability. Statistical analysis was performed using Graphpad prism
software; the data are presented as means ± S.D.
4.1.1 Cell viability assay (MTT). In this study we ran the test with different
concentration gradients and at different time courses.
4.1.1.1 Effect of hydrogen peroxide concentration on pericytes viability. When we
exposed the cells to H2O2 concentration of 0.0, 0.1, 0.5,1,10, 100 mM for 1 hour, we found that
the absorbance was highest at 0.1mM H2O2 compared to the untreated cell. The absorbance was
lowest at 100mM H2O2. Absorbance level varied in the other concentrations. This indicates that
the cell is more viable at 0.1 mM and less viable at 100mMcomparedto the untreated cells.
In figure 4 the values are presented as Means ± S.D from three samples. We observed that the
cell loses its viability at 100 mM H2O2. The viability increases when H2O2 concentration
decreases. The viability percentage is around 50 % at 1m M H2O2. This means that, above 1m M
H2O2 is harmful to the cells. We decided to repeat the test with different concentration, ranging
from 1to 0.1 mM. We chose H2O2 concentration of 0.0, 0.1, 0.2, 0.5, 1 mM and the control.
Figure 5 illustrates the cell viability; the values are presented as Means ± S.D from three
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samples. Comparing with the control, the figure shows that the cells were more viable at 0.1 mM
H2O2 and less viable at 1 mM H2O2. Above 0.5 mM H2O2 is harmful to the cell. So, to be able to
study the cell behavior under oxidative stress conditions, we should use H2O2concentration less
than 0.5 mM.
MTT viabilty

% viability

150

100 mM
10 mM
1 mM
0.5 mM
0.1 mM

100

50

0

H2O2 (mM) concentration gradient

Figure 4. Effect of H2O2 concentration on pericytes viability; 0.1, 0.5, 1, 10 and100 mM.
Statistical studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05;
n=3
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Figure 5. MTT viability assay with H2O2 concentration; 1, 0.5, 0.2 and 0.1 mM.
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Statistical studies show that the P value is significant using one way ANOVA test followed by
Tukey test (all pairwise comparisons). *, p<0.05 compared to 0.01mM. Values are Means ± S.D.
n=3
4.1.1.2 Effect of time exposure to hydrogen peroxide on pericytes viability. To
determine the time dependence of the cytotoxic potency of H2O2, we exposed the cell to 200 µM
H2O2 for 4 h, 3h, 2 h, 1 hour, 30 minutes and 0 minutes. We determined cytotoxicity as a
decrease in the cell viability compared to controls.

MTT Viability %
100

4h
3h
2h
1h
0.5h
0h

viability%

80
60
40
20
0

Time exposure for (0.2mM H2O2)

Figure 6. Effect of time exposure to hydrogen peroxide on pericytes viability.
Statistical studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05;
n=3
Figure 6 shows that there is a trend for difference, which looks like a time-dependent decrease in
viability of pericytes, with increased time exposure to hydrogen peroxide. However, these levels
did not reach formal significance. Statistical studies show that the P value is not significant.
4.1.2 Lactate dehydrogenase assay (LDH). We ran the LDH assay at diverse
timeframes until we recognized the toxic concentration that causes activation of the cells without
killing the cells. The various timeframes also enabled us to determine how long it takes to show
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the toxic effect of H2O2 on the human brain vascular pericytes cells. We set two courses;
concentration gradient and time course.
4.1.2.1. Effect of hydrogen peroxide concentration on pericytes with LDH. The
cytotoxicity was assessed with the LDH assay at H2O2 concentration; 1, 0.5, 0.2 and 0 mM for 1
hour exposure. Figure 7 shows a trend for difference in cytotoxicity to pericytes with decreased
hydrogen peroxide concentration but these levels did not reach formal significance. Statistical
studies show that the P value is not significant.

LDH Cytotoxicity

% cytotoxcity
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Figure 7. LDH cytotoxicity with H2O2 concentration; 1, 0.5 and 0.2mM H2O2.
Data are presented as mean ± S.D. from three experimental values one way ANOVA test with
tukey’s test showed that there is no significance deference , p>0.05.
4.1.2.2 Effect of time exposure to hydrogen peroxide on pericytes with LDH. As we did
in the viability test, we ran the LDH test to determine the time-dependence of the cytotoxic
potency of H2O2. We exposed the cell to 200 µM H2O2 for 4 h, 3h, 2 h, 1 h, 30 minutes and 0
minutes. The cytotoxicity is determined by the release of LDH into the culture media.
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Figure 8. Time-dependent LDH cytotoxicity test.
Statistical studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05;
n=3
Figure 8 shows that there is a trend for cytotoxicity increases with longer time exposure for H2O2
but these levels did not reach formal significance. Statistical studies show the P value has no
significant difference. At 4 h exposure, the H2O2 toxicity is around 80% and it is close to 50% at
1 h exposure.
Based on collected data, we chose to treat the pericytes with hydrogen peroxide at 100
µM and 200 µM for 1 h to produce oxidative stress condition similar to the hypoxic ischemic
injury.
4.1.3 Characterization of cellular morphologies. Morphology was used to measure any
changes in human brain vascular pericytes. Using the EVOS XL optical microscope, images
were captured of each well in 96-well plate before running cytotoxicity testing.
4.1.3.1 Morphological changes with hydrogen peroxide concentration gradient. Figure
9 (a) shows the normal pericytes cell morphology, which are spindle-shaped and have a nongranular cytoplasm. After cellular exposure for hydrogen peroxide at 100 and 200 µM we noted
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morphologic changes as cellular detachments from the surface, change of membrane integrity
and appearance of cytoplasm. The morphological changes were more evident in figure 9 (c)
where the cells were exposed to 200 µM H2O2 than in figure 9 (b) where the cells were exposed
to 100 µM H2O2.

9 (a) HBVP 0 µM H2O2.

9 (b) HBVP 100 µM H2O2.

9 (c) HBVP 200 µM H2O2.

Figure 9. HBVP cells after exposed to H2O2 concentration of (0, 100,200 µM) for 1 h.
Morphological changes were observed with 400X magnification micrograph.
4.1.3.2 Morphological changes with hydrogen peroxide time course. These pictures
were captured for pericytes cells just after they were treated with 200 µM H2O2 and then at the
time course of exposure before we ran the LDH test. Figure 10 (a) shows normal cell
morphology. As time increases, the morphological changes increase. Figure 10 (f) shows the
entire cells detached from the surface rounded and floated above the surface.
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0h

(b) 0.5h

(d) 2h

(e) 3h

(c) 1h

(f) 4h

Figure 10. HBVP cells after exposed to 200 µM of H2O2 for different time courses.
Morphological changes were observed with 400X magnification micrograph.
4.2 Intracellular protein expression
To evaluate the intracellular protein expression, the first step was staining the cells with
actins green stain. This allowed us to visualize the F-actin microfilament with
immunofluorescent microscopy. The second step was combining the actins green stain with the
secondary antibodies, which were labeled with red immunofluorescent stain for specific proteins
including; α-actin, myosin, tropomyosin, and PDGFR-β. After we captured the pictures, we
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analyzed them to study the intensity and distribution pattern. We used image J software to
measure the integrated density and calculate the intensity with prism program.
4.2.1 Effect of hydrogen peroxide on intracellular protein expression. The cells were
stained with green fluorescent stain to visualize F- actin cytoskeleton and stained with red
fluorescent stain to visualize α-actin, PDGFR-β, tropomyosin and myosin proteins in pericytes
cells. We calculated intensity using 8-12 images, values presented as means ± S.D.
4.2.1.1 Effect of hydrogen peroxide on F-actin proptein expression. We measured the
F-actin green stain intensity in the cell without exposure to hydrogen peroxide and after exposure
to 100 µM and 200 µM for 1hour. The graph in figure 11 shows that the intensity of the F-actin
green stains increases when the hydrogen peroxide concentration increases.

intensity (integrated density/cell)

F- actin green stain
1000000.0

***
800000.0

0 µM H2O2
100 µM H2O2
200 µM H2O2

600000.0
400000.0
200000.0
0.0

H2O2 concentration gradient (M)

Figure 11. Fluorescence intensity of F-actin in hydrogen peroxide treated pericytes. Statistical
studies show that the P value is significant. Values are Means ± S.D. ***, p< 0.0001; n=10
There is significant increase in fluorescent intensity of F- actin in hydrogen peroxide treated
pericytes as compared with control.
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To study the F-actin protein distribution pattern in cells, we applied immunofluorescent
microscopy to visualize the F-actin at 3 levels of concentration of H2O2: Control, 100 µM, and
200 µM.
F-actin(green)

Nuclei(blue)

Overlap

Control

100µM H2O2.

200µM H2O2.
Figure 12. Effect of hydrogen peroxide on F-actin morphology and distributions.
400 X magnification micrograph shows the formation of cellular protrusion, and formation of
nanotubes connecting the cells together when the cells treated with 100 µM H2O2 and 200 µM
H2O2.
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4.2.1.2 Effect of hydrogen peroxide on α-Actin protein expression. Figure 13 shows the
red stain intensity of the α-actin antibody, there is a trend of difference when cells exposed to
100 µM H2O2 but this level does not reach formal significance. P value is ns p > 0.05
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Figure 13. Fluorescence intensity of α-Actin in hydrogen peroxide treated pericytes. Statistical
studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05; n=9
There is no significant increase in fluorescent intensity of α Actin in hydrogen peroxide treated
pericytes.
Pericytes were treated with 100 and 200 µM H2O2 to study the distribution pattern of α-Actin.
0 µM H2O2

100 µM H2O2

200 µMH2O2

Figure 14. Effect of hydrogen peroxide on α-Actin morphology and distributions.
Distribution pattern of α-Actin was observed with 400X magnification micrograph.
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4.2.1.3 Effect of hydrogen peroxide on PDGFR-β protein expression. We studied the
PDGF-β protein intensity and distribution inside pericytes cells after treated with H2O2 for I h.
Figure15 shows the red stain intensity of the PDGFR-β antibody, when cells exposed to 100µM
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Figure 15. Fluorescence intensity of DGFR-β in hydrogen peroxide treated pericytes. Statistical
studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05; n=9
0 µM H2O2

100 µM H2O2

200 µM H2O2

Figure 16. Effect of hydrogen peroxide on PDGFR-β morphology and distributions.
Pericytes were treated with H2O2 for 1 h and subsequently immunostained for PDGFR-β.
PDGFR-β distribution pattern was observed with 400X magnification micrograph.
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4.2.1.4 Effect of hydrogen peroxide on myosin protein expression. The stain intensity in
Figure17 shows the red stain intensity of the myosin antibody, which increases when cells
exposed to 100 µM H2O2.
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Figure 17. Fluorescence intensity of myosin in hydrogen peroxide treated pericytes. Statistical
studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05; n= 8
0 µM H2O2

100 µM H2O2

200 µM H2O2

Figure 18. Effect of hydrogen peroxide on myosin morphology and distributions.
Myosin distribution pattern was observed with 400X magnification micrograph.
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4.2.1.5 Effect of hydrogen peroxide on tropomyosin protein expression. Figure 19
shows the red stain intensity of the tropomyosin antibody inside pericytes before they were
treated with hydrogen peroxide and after exposed to 100 µM H2O2 for 1 h.
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Figure 19. Fluorescence intensity of tropomyosin in hydrogen peroxide treated pericytes.
Statistical studies show that the P value is not significant. Values are Means ± S.D. ns, p>0.05;
n= 8
0 µM H2O2

100 µM H2O2
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Figure 20. Effect of hydrogen peroxide on tropomyosin morphology and distributions.
Tropomyosin distribution pattern was observed with 400X magnification micrograph.
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Figure 12 shows that F-actin the stain intensity increased with increased concentration of
hydrogen peroxide and the nucleus became granulated. We observed that H2O2 changed the
distribution and position of F-actin and pushed it toward the cell membrane. This in turn,
enhanced the formation of cellular protrusion, and formation of nanotubes connecting the cells
together.
As figures (14, 16, 18 and 20) illustrate, the red stain for contractile protein distribution and
pattern changes. Hydrogen peroxide enhances the protein movement toward the cell membrane.
After treatment with H2O2 pericytes tend to form connection with each other. Reorganization of
protein inside the cell was enhanced byH2O2 compared with non treated cells. Arrangement of
protein around the cell membrane facilitates protein spread out and formation of cell protrusions
and nanotubes between cells. This creates cell contraction and cell movement. This suggests that
the contractile protein inside the cells is affected by oxidative stress.
Additionally, oxidative stress increases PDGFR-β expiration on pericytes. PDGFR-β is
important in cell interaction between pericytes and endothelial cells. Endothelial cells secrets
PDGF-B, which bind to PDGFR-β receptor in pericytes. This interaction is essential for presence
pericytes in the vessels wall.
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CHAPTER 5
Discussion and Future Research

5.1 Discussion
In this study, we examined the effect of oxidative stress on the protein expression,
including F-actin, α-actin, PDGFR-β, tropomyosin, and myosin. We found that H2O2 increases
the intensity of the protein in the cells. Regarding the distribution pattern of protein in pericytes
cells, we observed that H2O2 changed this distribution. The protein changed position and moved
toward the cell membrane, while sometimes forming cellular protrusion connecting cells
together.
Our findings suggest that oxidative stress affect protein expression in HBVP cells,
leading to changes in their distribution and intensity, which affects their function. This indicates
that oxidative stress plays a role in cell contractility. Also, it plays a role in cell mobility and
movement. Hamilton et al. (2010) reported that pericytes are contractile cells containing actin,
myosin and tropomyosin microfilament. Yemisci et al. (2009) tested the effect of ischemic
condition on pericytes on microvessels in the intact mouse brain. He reported that pericytes
contraction was induced during ischemia. Our study on pericytes cell culture suggests that
oxidative stress induces pericytes contraction. Dehouck et al. (1997) found that activation of
pericytes endothelin-1 receptors lead to an elevation of intracellular calcium concentration,
which lead to vasoconstriction of the cultured capillary pericytes. A study by Lindaure (2010)
reported that vasoactive stimuli in an intact adult mouse brain leads to contraction of cortical
capillary pericytes. Our study is consistent with the study done by Zhu et al. (2005) regarding F-
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actin microfilament. We found that H2O2 increases F- actin expression and formation of cellular
protrusions in pericytes cell. Zhu et al. (2005) reported the same result but in astrocyte cells.
There are different researchers who studied the effect of oxidative stress on astrocytes
and they reported results similar to our results on pericytes. Qian et al. (2003) reported that
oxidative stress causes cytoskeletal reorganization in astrocyte cells. Ramirez-Weber et al.
(1999) described the effect of oxidative stress on the formation actin-enrriched protrusions.
Regarding PDGFR-β, our study observed that H2O2 increases its expression inside the cell.
PDGFR-β plays an important role in cell reaction between pericytes and endothelial cells. A
study by Winkler et al. (2010) pointed to the role of PDGFR-β in pericytes recruitment to the
vessel wall in the embryonic brain, regulating the development of the cerebral microcirculation
and the blood-brain barrier (BBB). The author also showed that PDGFR-β is exclusively
expressed in pericytes in the adult brain.
5.2 Conclusion
Pericytes are contractile cells, which are part of the neurovascular unit of the brain. They
are located around blood microvessels in contact with endothelial cells. They play a role in the
regulation of blood flow, vascular permeability, maintenance of microvessel wall integrity, and
angiogenesis. The number of pericytes present in brain microvessels is higher than any other part
of the body. To this date, the effect of oxidative stress on cerebrovascular pericytes cellular
function has not been fully investigated.
In our study, we examined the effects of oxidative stress on cultured pericytes at passage 4 by
exposing pericytes to H2O2, an oxidant commonly used to examine oxidative mechanisms
mediating cell toxicity and death. We investigated how H2O2 concentration and exposure time
affect cytotoxicity potency of H2O2 in vitro. Cytotoxicity tests measured the morphological effect
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and viability of HBVP exposed to H2O2. We exposed pericytes to H2O2 at concentration ranging
from 0.1 to 10 mM and exposure time ranging from 0 to 4 hours. Results from cytotoxicity tests
suggest that when we exposed the human brain vascular pericytes cells to 100 µM and 200 µM
for 1 hour, it showed the toxic effect of H2O2 on the human brain vascular pericytes cells without
killing the cells. So, we chose to use 100 µM and 200 µM for 1 hour exposure to study how
oxidative stress changes the proteins expression inside the cell.
5.3 Future Studies
The effect of oxidative stress on cerebrovascular pericytes cellular function has not been
fully investigated. There is still limited information about pericytes biology under ischemic
conditions. Future studies should illustrate in detail what and how oxidative stress may alter
pericytes cellular function. These studies should determine how oxidative stress changes
important cell membrane function receptors, i.e., Low-density lipoprotein receptor-related
protein 1 (LRP1), the receptor for advanced gtycation end products (RAGE), and Plateletderived growth factor receptor –β (PDGFR-β). Studies should investigate the changes of
expression level of these receptors and their translocation inside the cell after exposure to
oxidative stress.
Previous studies by Winkler et al. (2010) reported the role of PDGFR-β in mediating
pericytes recruitment to the vessel wall and regulating the development of the cerebral
microcirculation of BBB. So, future studies in PDGFR-β are needed to help explain the loss or
impaired recruitment of pericytes to the outside endothelial wall in pathological conditions like
AD and cerebral ischemia. Pericytes are contractile cells, which contain contractile protein like
α-actin, myosine, and tropomyosin. These contractile proteins are responsible for pericytes
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contraction. Future studies are, therefore, needed to provide information on how contractile
protein and related cytoskeletal proteins are regulated or altered by oxidative stress.
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